KIRSKE DAVID — SEC insider filings
SEC reporting owner CIK 1276750. 15 insider filings on record with FilingPulse; latest filed 2026-10-05.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2021-03-12 to 2026-10-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 19 legs across 9 filings — 327,055 shares, $1,896,998 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 53.
- Largest priced transaction: sale of 139,841 shares @ $6.05 ($845,549) in CTI BIOPHARMA CORP, filed 2022-10-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CTI BIOPHARMA CORP (CTIC) | EVP, Chief Financial Officer | 10 | — | 16 legs · 289,784 sh · $1,754,092 | 49 |
| X4 Pharmaceuticals, Inc (XFOR) | Chief Financial Officer | 5 | — | 3 legs · 37,271 sh · $142,907 | 4 |
Insider filings — KIRSKE DAVID
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-05 | 4 | X4 Pharmaceuticals, Inc (XFOR) | Sale (S): 11,767 @ $2.86 | EDGAR |
| 2026-07-01 | 4 | X4 Pharmaceuticals, Inc (XFOR) | Sale (S): 8,543 @ $4.26 | EDGAR |
| 2026-05-13 | 4 | X4 Pharmaceuticals, Inc (XFOR) | Sale (S): 16,961 @ $4.29 | EDGAR |
| 2025-10-31 | 4 | X4 Pharmaceuticals, Inc (XFOR) | Grant/award (A): 1,552,769 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | X4 Pharmaceuticals, Inc (XFOR) | Grant/award (A): 193,254 @ $0 · Grant/award (A): 1,073,249 (derivative) @ $0 · Grant/award (A): 352,800 (derivative) @ $0 | EDGAR |
| 2023-06-26 | 4 | CTI BIOPHARMA CORP (CTIC) | Code (U): 17,547 @ $9.10 · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 315,000 (derivative) · Disposition to issuer (D): 83,396 (derivative) · Disposition to issuer (D): 270,216 (derivative) · Disposition to issuer (D): 340,000 (derivative) · +3 more | EDGAR |
| 2023-03-16 | 4 | CTI BIOPHARMA CORP (CTIC) | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2023-01-03 | 4 | CTI BIOPHARMA CORP (CTIC) | Option exercise (M): 13,174 @ $0.95 · Sale (S): 13,174 @ $6 · Grant/award (A): 214 @ $5.11 · Option exercise (M): 12,000 @ $0.95 · Sale (S): 12,000 @ $6 · Option exercise (M): 800 @ $0.95 · +10 more | EDGAR |
| 2022-10-06 | 4 | CTI BIOPHARMA CORP (CTIC) | Option exercise (M): 1,400 @ $0.95 · Sale (S): 1,400 @ $6.25 · Option exercise (M): 100 @ $0.95 · Sale (S): 100 @ $6.26 · Option exercise (M): 609 @ $0.95 · Sale (S): 609 @ $6.27 · +3 more | EDGAR |
| 2022-10-03 | 4 | CTI BIOPHARMA CORP (CTIC) | Option exercise (M): 800 @ $0.95 · Sale (S): 800 @ $6 · Option exercise (M): 100 @ $0.95 · Sale (S): 100 @ $6.01 · Option exercise (M): 139,841 @ $0.95 · Sale (S): 139,841 @ $6.05 · +6 more | EDGAR |
| 2022-09-20 | 4 | CTI BIOPHARMA CORP (CTIC) | Grant/award (A): 9,516 @ $2.12 · Option exercise (M): 22,592 @ $0.95 · Sale (S): 22,592 @ $6.02 · Option exercise (M): 22,592 (derivative) @ $0 | EDGAR |
| 2022-06-17 | 4 | CTI BIOPHARMA CORP (CTIC) | Option exercise (M): 10,000 @ $1 · Sale (S): 10,000 @ $6 · Option exercise (M): 50,000 @ $3.30 · Sale (S): 50,000 @ $6.25 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | CTI BIOPHARMA CORP (CTIC) | Option exercise (M): 10,000 @ $0.95 · Sale (S): 10,000 @ $5.50 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2022-03-11 | 4 | CTI BIOPHARMA CORP (CTIC) | Grant/award (A): 1,782 @ $2.12 · Grant/award (A): 1,817 @ $2.11 · Grant/award (A): 280,000 (derivative) @ $0 | EDGAR |
| 2021-03-12 | 4 | CTI BIOPHARMA CORP (CTIC) | Grant/award (A): 3,798 @ $0.98 · Sale (S): 200,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-03-08 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1276750 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs